Showing results (2031-2040 of 6,773) with videos related to
Sort By:
Pageof 678
Clinical Therapeutics|July 25, 2006
A double-blind, randomized trial to evaluate the pharmacokinetics and tolerability of 30 or 40 mg/d oral olanzapine relative to 20 mg/d oral olanzapine in stable psychiatric subjectsMalcolm Mitchell, Robert Riesenberg, Mohammad A Bari, et al.Clinical Therapeutics|July 25, 2006
Effects of low-dose norethindrone acetate plus ethinyl estradiol (0.5 mg/2.5 microg) in women with postmenopausal symptoms: updated analysis of three randomized, controlled trialsJean P Rowan, James A Simon, Leon Speroff, et al.Clinical Therapeutics|July 25, 2006
Second-generation antidepressant discontinuation and depressive relapse in adult patients with bipolar depression: results of a retrospective database analysisAlex Z Fu, Dale B Christensen, Richard A Hansen, et al.Clinical Therapeutics|May 10, 2005
The role of luteinizing hormone-releasing hormone therapy in locally advanced prostate cancer and biochemical failure: considerations for optimal usePierre Teillac, Aldo V Bono, Jacques Irani, et al.Clinical Therapeutics|May 10, 2005
A retrospective chart review of the clinical effects of atypical antipsychotic drugs on glycemic control in institutionalized patients with schizophrenia and comorbid diabetes mellitusArthur Krosnick, Michael G WilsonClinical Therapeutics|January 11, 1992
Antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1989G J Cuchural, D R Snydman, L McDermott, et al.Clinical Therapeutics|January 1, 1992
Combination of nifedipine and carteolol compared to nifedipine alone in diurnal blood pressure variation and exercise blood pressure in patients with essential hypertensionI Inoue, H Matsuura, T Fujii, et al.Clinical Therapeutics|January 1, 1992
Loracarbef versus cefaclor in the treatment of cystitis and asymptomatic bacteriuriaA IravaniClinical Therapeutics|June 1, 2005
Optimizing the management of postmenopausal osteoporosis with bisphosphonates: the emerging role of intermittent therapyPaul D MillerClinical Therapeutics|June 1, 2005
Results of a multicenter, 8-week, parallel-group, randomized,double-blind, double-dummy, Phase III clinical trial to evaluate the efficacy and tolerability of amlodipine maleate versus amlodipine besylate in Korean patients with mild to moderate hypertensionSungha Park, Namsik Chung, Jun Kwon, et al.Pageof 678